Compare ARK Genomic Revolution ETF (ARKG) vs Direxion Daily S&P 500 Bull 3X Shares (SPXL) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Direxion Daily S&P 500 Bull 3X Shares — how do they compare? ARK Genomic Revolution ETF trades at $41.21, while Direxion Daily S&P 500 Bull 3X Shares trades at $276.27. Which is the better fit depends on your goals.
| ARKG | SPXL | |
|---|---|---|
Sector | Sector/Thematic | Leveraged / Inverse |
52-Week High | $43.57 | $288.04 |
52-Week Low | $23.09 | $170.20 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
SPXL trades at $279.18, up 1.22% on the day, with a bullish technical signal from moving averages. The stock faces resistance near $281-$285 while supported at $271-$274. Recent news highlights AI-driven market optimism but notes Fed policy and earnings as key near-term catalysts. A dividend of $0.52 is scheduled for June 30, 2026.
Outlook remains positive given strong AI sector momentum, though stretched valuations and Fed tightening risks warrant caution. Earnings growth and sector rotation will dictate direction, with technical indicators suggesting potential consolidation before further upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Direxion Daily S&P 500 Bull 3X Shares
SPXL aims for 300% of the S&P 500's daily performance. It uses swaps and futures to provide 3x leverage, making it a high-risk tool for short-term traders. Due to daily resets, it is prone to volatility decay and is not intended for long-term holding.
Read more on SPXL →
